Gapping up
In reaction to strong earnings/guidance:JASN +28.9%, SKYW +18.3%, HTCH +15.2%, YRCW +15.2%, COLM +11.7%, ZLTQ +10.9%, NSU +9.3%, ATEN +8.7%, ELLI +8.6%, CVEO +8.2%, MGI +7.9%, EXPE +7.8%, SAND +7.8%, NLNK +7.6%, MXWL +7.1%, ( selected as exclusive capacitive energy storage supplier by subsidiary of China's largest rail company, CRRC Corp), IMMR +6.7%, NGVC +6.3%, FRGI +6.1%, PXLW +5.5%, RCL +4.5%, FIX +4.1%, ( increases quarterly dividend), TRP +4%, AXL +4%, MOH +3.7%, BCOR +3.4%, (Blucora's Infospace subsidiary signs deal to distribute Bing search results and advertising content through the Infospace network of Web search properties and partner websites on desktop and mobile), WETF +3.4%, HMC +3.2%, TNP +3.2%, ISNS +3.1%, TNDM +3.1%, PFS +3.1%, AMGN +2.7%, TPX +2.3%, (appoints Barry Hytinen as EVP and CFO, effective immediately ), WU +2.3%, UHS +1.8%, AUY +1.6%, CRAY +1.4%, STX +1.4%, CATM +1.2%, CALD +1.1%, DGI +1%, RGC +1%, NWL +0.9%
M&A news: CCE +8.3% (WSJ report on merger talks)
Other news: MXWL +17.6% (selected as exclusive capacitive energy storage supplier by subsidiary of China's largest rail company, CRRC Corp; co also reported earnings), BCOR +3.4% (signed a three-year search and advertising deal to distribute Bing results through the Infospace network; co also reported earnings), TNDM +3.1% (entered into a non-exclusive Development Agreements with Dexcom (DXCM), to integrate future generation Tandem insulin pumps with the Dexcom G5 and G6 products; co also reported earnings), ENH +2.7% to replace TMST in the S&P MidCap 400), JUNO +1.9% ( announces US FDA clearance of its INDA regarding JCAR015, to treat Adult Relapsed/Refractory Acute Lymphoblastic Leukemia ), IDI +1.4% (Mitchell P. Kopin disclosed 8.2% passive stake in 13G filing), EVAR +1.3% (Lombard Medical acquires Altura Medical), SALT +1.1% (10.31% stakeholder Monarch Alternative Capital issues letter to Board; believes co should resume its asset sale program and use the proceeds to buy back stock)
Analyst comments: GPRO +4.4% (upgraded to Buy from Neutral at Citigroup), AIXG +4% (upgraded to Outperform at Exane BNP Paribas), WU +2.3% (upgraded to Equal Weight from Underweight at Barclays), UA +0.7% (upgraded to Buy at Argus), ALV +0.6% (upgraded to Outperform from Neutral at Credit Suisse), CB +0.5% (upgraded to Outperform from Mkt Perform at Bernstein)
In reaction to strong earnings/guidance:JASN +28.9%, SKYW +18.3%, HTCH +15.2%, YRCW +15.2%, COLM +11.7%, ZLTQ +10.9%, NSU +9.3%, ATEN +8.7%, ELLI +8.6%, CVEO +8.2%, MGI +7.9%, EXPE +7.8%, SAND +7.8%, NLNK +7.6%, MXWL +7.1%, ( selected as exclusive capacitive energy storage supplier by subsidiary of China's largest rail company, CRRC Corp), IMMR +6.7%, NGVC +6.3%, FRGI +6.1%, PXLW +5.5%, RCL +4.5%, FIX +4.1%, ( increases quarterly dividend), TRP +4%, AXL +4%, MOH +3.7%, BCOR +3.4%, (Blucora's Infospace subsidiary signs deal to distribute Bing search results and advertising content through the Infospace network of Web search properties and partner websites on desktop and mobile), WETF +3.4%, HMC +3.2%, TNP +3.2%, ISNS +3.1%, TNDM +3.1%, PFS +3.1%, AMGN +2.7%, TPX +2.3%, (appoints Barry Hytinen as EVP and CFO, effective immediately ), WU +2.3%, UHS +1.8%, AUY +1.6%, CRAY +1.4%, STX +1.4%, CATM +1.2%, CALD +1.1%, DGI +1%, RGC +1%, NWL +0.9%
M&A news: CCE +8.3% (WSJ report on merger talks)
Other news: MXWL +17.6% (selected as exclusive capacitive energy storage supplier by subsidiary of China's largest rail company, CRRC Corp; co also reported earnings), BCOR +3.4% (signed a three-year search and advertising deal to distribute Bing results through the Infospace network; co also reported earnings), TNDM +3.1% (entered into a non-exclusive Development Agreements with Dexcom (DXCM), to integrate future generation Tandem insulin pumps with the Dexcom G5 and G6 products; co also reported earnings), ENH +2.7% to replace TMST in the S&P MidCap 400), JUNO +1.9% ( announces US FDA clearance of its INDA regarding JCAR015, to treat Adult Relapsed/Refractory Acute Lymphoblastic Leukemia ), IDI +1.4% (Mitchell P. Kopin disclosed 8.2% passive stake in 13G filing), EVAR +1.3% (Lombard Medical acquires Altura Medical), SALT +1.1% (10.31% stakeholder Monarch Alternative Capital issues letter to Board; believes co should resume its asset sale program and use the proceeds to buy back stock)
Analyst comments: GPRO +4.4% (upgraded to Buy from Neutral at Citigroup), AIXG +4% (upgraded to Outperform at Exane BNP Paribas), WU +2.3% (upgraded to Equal Weight from Underweight at Barclays), UA +0.7% (upgraded to Buy at Argus), ALV +0.6% (upgraded to Outperform from Neutral at Credit Suisse), CB +0.5% (upgraded to Outperform from Mkt Perform at Bernstein)